Vitamin D and Staphylococcus Aureus in the Diabetes Study

Phase 3

Completed

• Conditions: Infection
• Interventions: Drug: cholecalciferol

• Registration Number: NCT01395290
• Lead Sponsor: University of Tromso

Brief Summary

There are indications that the vitamin D status of an individual is related to susceptibility to staphylococcal infections. In the present study we will examine nasal colonisation rate in subjects participating in an ongoing vitamin D intervention study ( 20.000 IU cholecalciferol per week vs placebo) for the prevention of type 2 diabetes in subjects with impaired glucose tolerance.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Study First Submitted: 2011-07-14
• Study First Submitted QC: 2011-07-14
• Study First Posted: 2011-07-15
• Primary Completion: 2012-05
• Study Completion: 2012-08
• Status Verified: 2012-09
• Last Update Submitted: 2012-09-03
• Last Update Posted: 2012-09-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 280

Inclusion Criteria

• participant in an ongoing intervention study with vitamin D

Exclusion Criteria

• none specifically for this study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
cholecalciferol	cholecalciferol	cholecalciferol 20.000 IU per week

Primary Outcome Measures

Name	Time	Method
nasal staphylococcus colonisation	6 months

Trial Locations

Locations (1)

University Hospital of North Norway; 🇳🇴 Tromsø, Norway